|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety and pharmacokineties of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43 - 9006,in patients with advanced refractory solid tumors显示文摘 | Clark JW Eder JP Ryan D | 2005 | Clin Cancer Res2005，11，： | 1 |
| 2 | Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects : a 5-year retrospective cohort study 显示文摘 | Lee JW Cho YK Ryan M | 2010 | Gut liv- er2010，4，3： | 1 |
| 3 | Weekly docetaxel,cisplatin,and irinotecan(TPC):results of a multicenter phase Ⅱ trial in patients with metastatic esophagogastric cancer显示文摘 | Enzinger PC Ryan DP Clark JW | 2009 | Ann Oncol2009，20，3： | 1 |
| 4 | Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY439006, in patient with advanced, refractory solid tumor 显示文摘 | Clark JW Eder JP Ryan D | 2005 | Clin Cancer Res2005，11，15： | 1 |
| 5 | A phase II study of modified deGramont 5-fluorouracil,leucovorin,and oxaliplatin in previously treated patients with metastatic colorectal cancer显示文摘 | Ryan DP Clark JW Kulke MH | 2003 | Cancer Invest2003，21，4： | 1 |
| 6 | Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry 显示文摘 | Ryan JW Peterson ED Chen AY | 2005 | Circulation2005，112，20： | 1 |
| 7 | Coordinate up-regulation of hypoxia inducible factor (HIF)-la and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing显示文摘 | Elson DA Ryan HE Snow JW | | Cancer Res0，2，： | 1 |
| 8 | The ultrastructural basis of endothelial cell surface functions显示文摘 | Ryan US Ryan JW | 1984 | Biorheology1984，21，： | 1 |
| 9 | The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration显示文摘 | Campochiaro PA Soloway P Ryan SJ Miller JW | 1999 | Mol Vis1999，5，： | 1 |
| 10 | Right ventricular infarction显示文摘 | Ryan TJ | 1994 | N Engl J Med1994，330，17： | 1 |
| 11 | Coronary risk area measurement by intracardiac echocardiography and ultrasound contrast 显示文摘 | Bissing JW Ryan AJ Kerber RE | 2001 | J Am Soc Echocardiogr2001，14，： | 1 |
| 12 | Weekly docetaxel,cisplatin and irinotecan(TPC):results of a multicenter phase Ⅱ train in patients with metastatic esophagogastric cancer显示文摘 | Enzinger PC Ryan DP Clark JW | 2009 | Ann Oncol2009，20，3： | 1 |
| 13 | Movement of the femoral head after Salter osteotomyfor acetabular dysplasia 显示文摘 | 〔6〕 Chung JW Ryan M Obrien TM | 1990 | J Bone Joint Surg(Br)1990，，： | 1 |
| 14 | Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes:insights from the CRUSADE(Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the ACC/AHA guidelines) Registry显示文摘 | Ryan JW Peterson ED Chen AY | 2005 | Circulation2005，112，20： | 1 |
| 15 | Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43 -9006, in patients with advanced, refractory solid tumors显示文摘 | Clark JW Eder JP Ryan D | 2005 | Clin Cancer Res2005，11，15： | 1 |
| 16 | Weekly docetaxel, cis- platin, and irinotecan (TPC) : results of a multicenter phase II tri- M in patients with metastatic esophagogastric cancer显示文摘 | Enzinger PC Ryan DP Clark JW | 2009 | Ann On- col2009，20，： | 1 |
| 17 | Weekly docetaxel, cisplatin, and irinotecan (TPC) : results of a muhicenter phase Ⅱ trial in patients with metastatic esophagogastrie cancer 显示文摘 | Enzinger PC Ryan DP Clark JW | 2009 | Ann Oncol2009，20，3： | 1 |
| 18 | Weekly docetaxel cisplatin and irinotecan TPC results of a muhicenter phase trial in patients with metastatic esophagogastric cancer显示文摘 | Enzinger PC Ryan DP Clark JW | 2009 | Ann Oncol2009，20，3： | 1 |
| 19 | Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes:insights from the CRUSADE(Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the ACC/AHA guidelines Registry显示文摘 | Ryan JW Peterson ED Chen AY | | 0，，20： | 1 |
| 20 | Safety and pharmacoki2 netics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor,BAY 43-9006,in patients with advanced,refractory solid tumors显示文摘 | Clark JW Eder JP Ryan D | 2005 | Clin Cancer Res2005，11，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员